Medicines Discovery Catapult and the Medical Research Council (MRC) Centre for Drug Safety Science (CDSS) have agreed a memorandum of understanding to combine their academic and industry expertise developing next generation 3D human cell models and creating robust cellular platforms.
The purpose of the collaboration is to identify and establish projects focused on the development of human 3D cell models and robust cellular platforms.
CDSS brings extensive experience in pre-clinical safety and in the establishment of new models and techniques that are clinically relevant. Medicines Discovery Catapult brings drug discovery expertise capabilities and a rapidly developing suite of cutting-edge research technologies as well as a close relationship with the life science and technology communities.
The partnership will combine the cell biology and pharmacology expertise of CDSS with Medicines Discovery Catapult’s organ-on-a-chip capabilities to explore ground-breaking opportunities to connect together multiple organ models to further improve patient relevance.